Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet · 2020 · 29.1K citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +12

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Mayla Gabriela Silva Borba, Fernando Val, Vanderson de Souza Sampaio et al. · JAMA Network Open · 2020 · 977 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

Zhaowei Chen, Jijia Hu, Zongwei Zhang et al. · medRxiv · 2020 · 891 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10